Get started
Author

G. Andrisani

Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti‐TNF alpha: 5‐year follow‐up study
2015 · D. Pugliese, L. Guidi, et al. · Alimentary Pharmacology & Therapeutics · 114
Infliximab in Steroid-dependent Ulcerative Colitis
2013 · Alessandro Armuzzi, Daniela Pugliese, et al. · Inflammatory Bowel Diseases · 74
A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: Infliximab and surgery
2012 · G. Andrisani, L. Guidi, et al. · Journal of Crohn s and Colitis · 23
Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis
2013 · G. Andrisani, E. Gremese, et al. · Reumatismo · 6
PDF
P363 Retreatment with infliximab in inflammatory bowel disease: tolerability and effectiveness of different re-induction regimens
2014 · C. Felice, D. Pugliese, et al. · Journal of Crohn s and Colitis · 5
P.96 Effect of Anti-tnf-alpha Treatment on Short-term Post-operative Complications in Patients With Inflammatory Bowel Disease
2010 · D. Pugliese, G. Rizzo, et al. · Digestive and Liver Disease · 5
P.16.15 Prevention of Postoperative Recurrence With Azathioprine or Anti-tnf Alpha in Patients With Crohn's Disease: a Pilot Study
2012 · A. Armuzzi, C. Felice, et al. · Digestive and Liver Disease · 3
Endoscopic Submucosal Dissection for High-Risk Colorectal Colitis-Associated Neoplasia in Inflammatory Bowel Disease: a Real-World Multicenter Study
2024 · R. Maselli, R. de Sire, et al. · Endoscopy · 2
P.06.20 Role of Trough Levels and Antibodies to Infliximab in the Evaluation of Loss of Response and Infusion Reactions to Infliximab Therapy in Inflammatory Bowel Disease
2014 · M. Marzo, A. Armuzzi, et al. · Digestive and Liver Disease · 2
PDF
P521 Cytomegalovirus infection and response to influenza vaccination in inflammatory bowel disease patients on anti-TNF therapy
2014 · L. Guidi, G. Andrisani, et al. · Journal of Crohn s and Colitis · 1
P.01.3 Long Term Sustainability of Mucosal Healing in Ulcerative Colitis Patients Treated With Infliximab
2013 · A. Armuzzi, G. Andrisani, et al. · Digestive and Liver Disease · 1
PDF
P214 Faecal calprotectin assay after induction with anti-TNF alpha agents in IBD patients: prediction of clinical response and mucosal healing at one year
2013 · L. Guidi, M. Marzo, et al. · Journal of Crohn s and Colitis · 1
Oc.09.2: Endoscopic Submucosal Dissection for High-risk Colorectal Colitis-associated Neoplasia in Inflammatory Bowel Disease: a Real-world Multicenter Study
2024 · R. Maselli, R. De Sire, et al. · Digestive and Liver Disease
The Hybrid-APC study: initial results of a Multicenter Observational Study on Barrett Esophagus treatment
2024 · R. Maselli, D. Massimi, et al. · Endoscopy
P.06.21 Retreatment With Infliximab in Inflammatory Bowel Disease: Tolerability and Effectiveness of Different Re-induction Regimens
2014 · C. Felice, D. Pugliese, et al. · Digestive and Liver Disease
P.02.4 a Single-center Cohort Study on Tolerability of Shortened One-hour Infliximab Infusion Times in Ibd Patients
2013 · L. Guidi, M. Marzo, et al. · Digestive and Liver Disease
PDF
Oc.08.2 Role of Faecal Calprotectin in Ibd Patients After Induction With Anti-tnf Alpha Agents in Predicting Clinical Response and Mucosal Healing at One Year
2013 · L. Guidi, M. Marzo, et al. · Digestive and Liver Disease
P.01.1 Long-term Outcome in Steroid-dependent Ulcerative Colitis Treated With Infliximab
2013 · A. Armuzzi, D. Pugliese, et al. · Digestive and Liver Disease
PDF
P442 Long-term outcome of treatment with infliximab in patients with steroid-dependent ulcerative colitis
2013 · A. Armuzzi, D. Pugliese, et al. · Journal of Crohn s and Colitis
N002 Tolerability of shortened one-hour infliximab infusion times in IBD patients: a single-center cohort study
2013 · L. Guidi, M. Marzo, et al. · Journal of Crohn s and Colitis
Long-Term Outcome of Treatment With Infliximab in Patients With Steroid-Dependent Ulcerative Colitis
2013 · Armuzzi A, Pugliese D, et al. · Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele
P.05.3 Complex Perianal Crohn's Disease: Effectiveness of Combined Seton Placement and Anti-tnf Alpha Agents in Monotherapy or in Association With Immunosuppressants
2012 · A. Armuzzi, M. Marzo, et al. · Digestive and Liver Disease
P.05.5 Predictive Factors of One-year Mucosal Healing in a Cohort of Ulcerative Colitis Patients Treated With Infliximab
2012 · A. Papa, G. Andrisani, et al. · Digestive and Liver Disease
P.16.6 Efficacy and Safety of Low-molecular Weight Heparin for the Prevention of Venous Thromboembolism in Patients With Severe Ulcerative Colitis
2012 · A. Papa, A. Armuzzi, et al. · Digestive and Liver Disease
P248 Infliximab in steroid-dependent ulcerative colitis: Efficacy and predictors of clinical and endoscopic remission
2012 · A. Armuzzi, D. Pugliese, et al. · Journal of Crohn s and Colitis
Works count: 46
Citation count: 237
H-index: 5
I10-index: 3
Year
Topic
Type